Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
VSEE	VSEE HEALTH INC	$5.49M	-11,570.70%	-68.20%	-153.43%	94.90%	2.01	0.41	46.30%	-92.40%	-76.65%
XTNT	XTANT MEDICAL HOLDINGS INC	$58.49M	3.70%	1.90%	12.04%	9.80%	0.61	3.34	62.30%	1.50%	5.85%
CYCN	CYCLERION THERAPEUTICS INC	$14.98M	-62.10%	-55.10%	-77.69%	-103.70%	0.25	1.80	100.00%	-264.70%	-264.73%
SDEV	STABLECOIN DEVELOPMENT CORP	$37.42M	-284.40%	-172.80%	-46.88%	-206.10%	0.30	5.33	N/A	N/A	N/A
RDHL	REDHILL BIOPHARMA LTD	$0.00	N/A	-2.00%	-4.75%	3.60%	4.94	0.34	100.00%	-150.00%	-101.75%
OGN	ORGANON & CO	$3.56B	29.90%	1.90%	9.79%	7.90%	13.39	1.97	52.80%	4.00%	16.68%
OGEN	ORAGENICS INC	$2.62M	-177.30%	-121.30%	-151.99%	-1,916.60%	0.21	5.73	N/A	N/A	N/A
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$6.17M	-160.30%	-102.00%	-194.70%	-235.30%	0.88	2.27	-147.60%	-3,376.30%	-3,374.04%
RNAZ	TRANSCODE THERAPEUTICS INC	$7.38M	-912.20%	-52.50%	-26.28%	12,304.90%	10.10	3.11	N/A	N/A	N/A
BOLT	BOLT BIOTHERAPEUTICS INC	$7.71M	-100.90%	-48.20%	-72.71%	-47.80%	1.42	3.51	100.00%	-455.10%	-455.15%
IBO	IMPACT BIOMEDICAL INC	$51.43M	-2,674.60%	-71.70%	-96.86%	2,943.50%	0.21	0.22	-1,012.80%	-32,969.20%	-38,246.15%
CCEL	CRYO CELL INTERNATIONAL INC	$29.08M	N/A	-4.30%	-1.78%	-1.50%	-4.31	0.62	77.50%	-8.50%	-2.45%
XTLB	XTL BIOPHARMACEUTICALS LTD	$8.91M	-269.00%	-159.90%	2,740.94%	1,450.40%	-1.65	0.40	N/A	N/A	N/A
AMS	AMERICAN SHARED HOSPITAL SERVICES	$10.20M	-6.40%	-2.60%	-0.56%	-0.30%	1.19	0.77	18.60%	-5.30%	-0.60%
CDT	CDT EQUITY INC	$2.21M	-4,720.10%	-531.60%	542.61%	-64,841.70%	-1.79	0.34	N/A	N/A	N/A
COSM	COSMOS HEALTH INC	$14.70M	-96.50%	-32.60%	-63.21%	-47.90%	2.15	1.08	10.40%	-30.40%	-25.74%
CPHI	CHINA PHARMA HOLDINGS INC	$27.68M	-19.00%	-13.40%	-9.10%	-98.80%	0.22	0.28	7.30%	-88.80%	-86.31%
ARAY	ACCURAY INC	$32.24M	-77.50%	-10.10%	-6.30%	-4.70%	9.73	1.42	26.80%	-10.80%	-3.56%
BMGL	BASEL MEDICAL GROUP LTD	$11.02M	-155.90%	-59.70%	-80.45%	-64.40%	2.18	1.88	75.80%	-68.00%	-67.47%
NXGL	NEXGEL INC	$4.93M	-70.20%	-29.60%	-38.15%	-40.00%	1.78	1.70	38.90%	-28.50%	-28.05%
VVOS	VIVOS THERAPEUTICS INC	$6.70M	-2,432.60%	-98.10%	-351.66%	-227.70%	-18.85	0.27	61.80%	-127.70%	-127.70%
COCP	COCRYSTAL PHARMA INC	$14.34M	-150.60%	-97.90%	-169.89%	-368.00%	0.80	2.66	N/A	N/A	N/A
IPHA	INNATE PHARMA SA	$175.26M	N/A	-56.60%	-176.67%	-145.70%	-3.89	1.28	100.00%	-546.10%	-511.46%
INM	INMED PHARMACEUTICALS INC	$5.34M	-82.00%	-69.10%	-122.64%	-668.50%	0.33	3.12	35.90%	-262.20%	-261.62%
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$5.89M	-78.80%	-72.90%	-73.20%	-373.40%	0.07	15.76	100.00%	-40,152.50%	-40,070.70%
SEER	SEER INC	$120.41M	-26.60%	-23.50%	-26.87%	-26.50%	0.13	17.73	48.70%	-464.80%	-464.06%
CLLS	CELLECTIS SA	$238.86M	-80.70%	-20.50%	-21.82%	-14.00%	3.83	1.52	100.00%	-89.50%	-44.93%
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$25.73M	-63.90%	-48.80%	-65.42%	-329.50%	0.39	6.06	N/A	N/A	N/A
NVNO	ENVVENO MEDICAL CORP	$7.41M	-66.40%	-60.40%	-78.56%	-69.30%	0.10	11.89	N/A	N/A	N/A
ZJYL	JIN MEDICAL INTERNATIONAL LTD	$15.50M	4.10%	2.40%	4.75%	4.00%	0.80	1.86	29.20%	5.80%	6.80%
YDES	YD BIO LTD	$165.65M	N/A	-67.70%	-68.50%	464.80%	-5.83	5.88	28.10%	-1,392.60%	-1,392.86%
SLP	SIMULATIONS PLUS INC	$370.97M	-49.30%	-45.60%	-49.42%	-243.70%	0.10	5.47	62.00%	-78.00%	-82.32%
TOVX	THERIVA BIOLOGICS INC	$11.61M	-190.80%	-64.20%	-76.68%	-133.80%	1.48	1.63	100.00%	-7,656.30%	-7,153.00%
MBAI	CHECK-CAP LTD	$8.14M	416.70%	105.30%	120.80%	878.70%	1.18	0.05	N/A	N/A	N/A
CELU	CELULARITY INC	$23.16M	N/A	-76.50%	-319.76%	-108.70%	-3.82	0.15	24.40%	-345.80%	-320.00%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$4.25M	-88.40%	-84.70%	-93.95%	5,616.30%	0.05	19.69	66.90%	-192,066.30%	-192,066.27%
LSTA	LISATA THERAPEUTICS INC	$30.51M	-101.90%	-83.10%	-155.79%	3,961.70%	0.31	4.23	100.00%	-9,618.20%	-9,845.88%
BYSI	BEYONDSPRING INC	$73.60M	N/A	-29.10%	-122.27%	-134.80%	-1.41	1.09	N/A	N/A	N/A
AIXC	AIXCRYPTO HOLDINGS INC	$22.06M	-105.90%	-89.50%	-89.08%	-274.90%	0.09	11.57	N/A	N/A	N/A
CCRN	CROSS COUNTRY HEALTHCARE INC	$426.79M	-27.10%	-19.80%	-23.33%	-45.90%	0.44	3.29	20.20%	-9.80%	-8.39%
SNYR	SYNERGY CHC CORP	$3.14M	N/A	-110.70%	2,278.03%	-26.90%	-1.25	0.93	65.40%	-57.00%	-31.84%
PMI	PICARD MEDICAL INC	$13.19M	N/A	-180.80%	-559.93%	493.70%	4.95	1.11	-4.10%	-546.60%	-436.72%
AYTU	AYTU BIOPHARMA INC	$23.51M	-148.90%	-28.20%	-60.65%	-418.50%	2.18	1.12	64.80%	-60.20%	-55.42%
NSRX	NASUS PHARMA LTD	$30.97M	N/A	-204.70%	-208.87%	22,392.50%	0.81	2.25	N/A	N/A	N/A
CANF	CAN-FITE BIOPHARMA LTD	$4.98M	-178.20%	-105.50%	-144.89%	-535.10%	0.70	3.46	100.00%	-2,426.70%	-2,426.67%
NSPR	INSPIREMD INC	$33.12M	-112.00%	-86.30%	-108.97%	-183.70%	0.30	5.15	28.10%	-473.00%	-472.40%
BCDA	BIOCARDIA INC	$13.31M	-5,456.10%	-232.70%	729.36%	502.30%	-2.61	0.41	N/A	N/A	N/A
VRXA	VERAXA BIOTECH HOLDING AG	$309.68M	N/A	-20.00%	-90.29%	-20.20%	-6.13	0.44	66.00%	-284,359.20%	-286,029.75%
BOLD	BOUNDLESS BIO INC	$56.16M	-53.60%	-34.70%	-42.62%	-30.60%	0.63	9.87	N/A	N/A	N/A
BJDX	BLUEJAY DIAGNOSTICS INC	$1.20M	-144.30%	-115.00%	-164.95%	-802.80%	0.34	2.81	N/A	N/A	N/A
NRSN	NEUROSENSE THERAPEUTICS LTD	$22.66M	-2,175.00%	-397.10%	747.65%	936.10%	-1.66	0.31	N/A	N/A	N/A
MLEC	MOOLEC SCIENCE SA	$5.60M	N/A	N/A	N/A	N/A	5.81	0.15	39.30%	N/A	N/A
BMRA	BIOMERICA INC	$5.35M	-98.10%	-70.40%	-125.20%	-202.70%	0.47	2.64	4.30%	-96.50%	-96.00%
BNBX	BNB PLUS CORP	$2.59M	-489.00%	-410.70%	-289.11%	-533.60%	0.12	1.82	46.80%	-2,389.00%	-1,679.62%
BFRI	BIOFRONTERA INC	$14.85M	-476.70%	-49.90%	-76.36%	-113.00%	3.08	1.21	77.30%	-25.70%	-24.50%
ZTEK	ZENTEK LTD	$50.02M	-81.70%	-57.60%	-83.34%	-70.10%	0.54	0.64	-1,019.00%	-5,882.60%	-5,798.51%
CABR	CARING BRANDS INC	$12.36M	N/A	N/A	N/A	N/A	-0.19	5.65	N/A	N/A	N/A
MODD	MODULAR MEDICAL INC	$25.12M	-286.30%	-216.30%	-217.92%	-523.10%	0.15	4.03	N/A	N/A	N/A
CALC	CALCIMEDICA INC	$15.61M	N/A	-139.10%	-553.70%	-171.10%	-8.80	1.61	N/A	N/A	N/A
JSPR	JASPER THERAPEUTICS INC	$13.05M	-523.00%	-138.60%	-457.29%	698.80%	5.23	2.26	N/A	N/A	N/A
TALK	TALKSPACE INC	$877.77M	1.00%	0.90%	-2.55%	-4.10%	0.21	4.84	42.20%	0.50%	-1.21%
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$32.98M	-26.10%	-15.00%	-17.50%	-16.10%	0.52	1.14	20.50%	-60.00%	-47.51%
BGMS	BIO GREEN MED SOLUTION INC	$5.19M	-233.90%	-201.00%	-45.48%	-258.20%	0.12	7.06	18.40%	-933.00%	-201.84%
KAPA	KAIROS PHARMA LTD	$8.33M	-92.30%	-86.40%	-109.90%	-284.40%	0.08	10.31	N/A	N/A	N/A
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-64.70%	-38.70%	-51.95%	-1,148.60%	0.59	2.03	N/A	N/A	N/A
BIVI	BIOVIE INC	$15.84M	-101.30%	-90.30%	-125.77%	-2,518.70%	0.12	9.97	N/A	N/A	N/A
TBPH	THERAVANCE BIOPHARMA INC	$876.40M	43.80%	25.50%	31.49%	62.00%	0.63	13.14	100.00%	104.30%	126.38%
TBRG	TRUBRIDGE INC	$393.73M	2.50%	1.10%	3.21%	5.40%	1.28	1.78	53.20%	1.30%	3.21%
TCRT	ALAUNOS THERAPEUTICS INC	$5.11M	-165.90%	-123.50%	-319.02%	-490.80%	0.46	1.63	100.00%	-136,966.70%	-136,966.67%
CUPR	CUPRINA HOLDINGS (CAYMAN) LTD	$15.18M	-1,569.10%	-91.20%	-86.45%	663.90%	0.68	2.35	-1.30%	-9,366.80%	-9,337.38%
NEUP	NEUPHORIA THERAPEUTICS INC	$18.59M	-76.90%	-54.80%	-53.47%	815.70%	0.18	14.31	100.00%	131,387.10%	134,189.48%
BBLG	BONE BIOLOGICS CORP	$2.59M	-50.40%	-47.40%	-61.20%	-10,769.80%	0.07	16.09	N/A	N/A	N/A
NEPH	NEPHROS INC	$38.54M	7.70%	5.90%	7.00%	13.60%	0.29	4.55	59.90%	4.10%	4.13%
NCNA	NUCANA PLC	$0.00	-153.70%	-116.10%	-83.75%	1,556.30%	0.23	5.48	N/A	N/A	N/A
NCEL	NEWCELX LTD	$18.73M	-191.80%	-121.40%	-114.48%	549.10%	0.58	0.76	N/A	N/A	N/A
TECH	BIO-TECHNE CORP	$11.10B	5.50%	4.30%	6.49%	12.30%	0.22	4.49	65.00%	9.00%	12.86%
BCAB	BIOATLA INC	$7.59M	N/A	-309.40%	417.43%	886.00%	-1.23	0.15	100.00%	-2,530.80%	-2,530.85%
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$4.02M	-204.30%	-131.30%	-283.08%	-259.00%	0.94	1.32	N/A	N/A	N/A
APUS	APIMEDS PHARMACEUTICALS US INC	$12.98M	-54.60%	-50.00%	-31.23%	-56.10%	0.12	0.90	N/A	N/A	N/A
ENTX	ENTERA BIO LTD	$84.18M	-88.00%	-74.80%	-107.43%	2,570.90%	0.23	7.93	N/A	N/A	N/A
APRE	APREA THERAPEUTICS INC	$9.29M	-61.00%	-50.20%	-29.63%	491.00%	0.15	8.92	100.00%	-9,696.00%	-10,168.19%
ESLA	ESTRELLA IMMUNOPHARMA INC	$43.89M	N/A	-397.40%	251.42%	140.10%	-1.69	0.24	N/A	N/A	N/A
KYNB	KYNTRA BIO INC	$29.35M	-208.50%	120.20%	211.56%	172.20%	-2.72	3.61	40.70%	2,199.40%	2,318.26%
AZTR	AZITRA INC	$2.41M	-251.50%	-186.00%	-111.53%	-838.40%	0.16	6.94	N/A	N/A	N/A
APGE	APOGEE THERAPEUTICS INC	$10.06B	-32.60%	-31.30%	-21.76%	-42.00%	0.03	32.59	N/A	N/A	N/A
MRKR	MARKER THERAPEUTICS INC	$24.68M	-73.30%	-59.70%	-79.09%	1,100.20%	0.26	4.79	100.00%	-340.80%	-341.26%
ATNM	ACTINIUM PHARMACEUTICALS INC	$30.15M	-218.70%	-43.40%	-61.62%	789.70%	18.72	5.89	100.00%	-26,078.90%	-26,078.89%
MOLN	MOLECULAR PARTNERS AG	$150.04M	-66.10%	-54.50%	-68.60%	-267.80%	0.28	9.43	N/A	N/A	N/A
BLRX	BIOLINERX LTD	$16.48M	-47.70%	-21.80%	-30.91%	-521.50%	1.08	1.58	79.20%	-634.10%	-554.92%
MNOV	MEDICINOVA INC	$70.88M	-27.30%	-25.20%	-29.57%	-459.50%	0.08	9.09	8.00%	-1,964.30%	-1,963.34%
MNDR	MOBILE-HEALTH NETWORK SOLUTIONS	$2.04M	-47.60%	-36.50%	-30.96%	-353.70%	0.19	4.22	19.70%	-35.30%	-35.33%
LFWD	LIFEWARD LTD	$24.57M	-243.10%	-97.40%	-110.42%	-267.70%	4.31	2.40	36.60%	-123.70%	-120.25%
MLSS	MILESTONE SCIENTIFIC INC	$30.83M	-166.30%	-56.60%	-145.72%	-135.20%	2.49	1.51	71.00%	-51.30%	-50.83%
IMCC	IM CANNABIS CORP	$958.39k	N/A	-39.70%	242.42%	-97.10%	-5.71	0.55	15.00%	-27.40%	-19.14%
BRTX	BIORESTORATIVE THERAPIES INC	$10.09M	-423.80%	-193.30%	-365.43%	-3,005.60%	0.53	2.35	92.10%	-3,089.60%	-3,089.55%
LUCY	INNOVATIVE EYEWEAR INC	$7.94M	-83.40%	-76.00%	-96.81%	-270.40%	0.13	8.02	17.50%	-272.50%	-272.48%
GCTK	GLUCOTRACK INC	$1.99M	-582.00%	-220.10%	2,713.25%	1,205.50%	-6.12	0.85	N/A	N/A	N/A
AIMD	AINOS INC	$17.39M	-160.60%	-62.30%	-84.12%	-123.30%	2.88	0.56	79.20%	-76,996.20%	-73,080.76%
AIM	AIM IMMUNOTECH INC	$4.33M	N/A	-221.40%	-503.44%	667.80%	3.04	1.01	-29.80%	-14,123.40%	-13,068.09%
GNTA	GENENTA SCIENCE SPA	$39.37M	-38.00%	-28.00%	-21.93%	-32.70%	0.46	14.16	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	607	-0.35%	+1.25%	+17.06%	+23.30%	18.36x	5.58x	-117.23%	-12.44%	-9.70%	+53.25%	Strong Buy
Diagnostics & Research	52	-0.02%	+3.31%	+13.74%	+24.32%	12.22x	3.90x	-7.05%	+5.99%	+11.73%	+5.79%	Strong Buy
Drug Manufacturers - General	20	-1.78%	-1.15%	+6.00%	+41.69%	41.49x	7.69x	+34.41%	+12.47%	+22.05%	+5.17%	Buy
Drug Manufacturers - Specialty & Generic	76	-0.55%	+0.67%	+5.56%	-33.67%	-5.96x	1.59x	+7.48%	+4.58%	+50.37%	+33.52%	Strong Buy
Healthcare Plans	10	-1.69%	+1.38%	+4.28%	+24.98%	29.47x	2.54x	+8.80%	+2.75%	+6.81%	-4.37%	Buy
Health Information Services	53	+0.95%	+5.82%	+18.00%	-47.94%	13.03x	3.44x	-8.71%	-0.43%	-0.74%	+17.15%	Buy
Medical Care Facilities	49	-0.40%	+5.21%	+14.56%	-22.16%	16.94x	5.47x	-49.37%	+6.58%	+14.89%	+11.00%	Buy
Medical Devices	135	+0.32%	+2.05%	+7.00%	-99.44%	20.88x	3.11x	+6.02%	+5.31%	+8.92%	+25.36%	Strong Buy
Medical Distribution	10	-0.08%	+4.19%	+6.35%	+10.62%	25.05x	156.87x	-97.12%	+3.72%	+24.95%	+17.15%	Buy
Medical Instruments & Supplies	54	+0.29%	+3.84%	+8.63%	-1.99%	45.23x	3.44x	+5.72%	+6.68%	+10.17%	+19.56%	Strong Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 72.73% over the past year, overperforming other healthcare stocks by 168 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 27.33% from Bioventus's current stock price of $11.78.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: B, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -7 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates ICCC as a "A".It passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 53.94% over the past year, overperforming other healthcare stocks by 149 percentage points.

3. Electromed (NYSEMKT:ELMD)

Electromed (NYSEMKT:ELMD) is the #3 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Electromed (NYSEMKT:ELMD) is: Value: C, Growth: C, Momentum: B, Sentiment: A, Safety: B, Financials: A, and AI: C.

Electromed (NYSEMKT:ELMD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 15 out of 33 due diligence checks and has strong fundamentals. Electromed has seen its stock return 130.17% over the past year, overperforming other healthcare stocks by 225 percentage points.

Electromed has an average 1 year price target of $38.00, a downside of -17.94% from Electromed's current stock price of $46.31.

Electromed stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Electromed, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 74 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 33.28%, which is 31 percentage points higher than the healthcare sector average of 2.65%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 16%, which is 13 percentage points higher than the healthcare sector average of 2.65%.

Siga Technologies's dividend payout ratio of 206.9% indicates that its high dividend yield might not be sustainable for the long-term.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 14.02%, which is 11 percentage points higher than the healthcare sector average of 2.65%.

Embecta's dividend payout ratio of 31.2% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and up 2.16% over the last week. Adapthealth was the among the top losers in the healthcare sector, dropping -4.55% yesterday.

AdaptHealth shares are trading lower after Baird lowered its price target on the stock from $18 to $15.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 43, which is 30 points higher than the healthcare sector average of 13. It passed 3 out of 7 valuation due diligence checks.

Embecta's stock has dropped -67.3% in the past year. It has overperformed other stocks in the healthcare sector by 27 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 73 points higher than the healthcare sector average of 13. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 514.31% in the past year. It has overperformed other stocks in the healthcare sector by 609 percentage points.

3. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 57, which is 44 points higher than the healthcare sector average of 13. It passed 4 out of 7 valuation due diligence checks.

Inmode's stock has dropped -3.31% in the past year. It has overperformed other stocks in the healthcare sector by 91 percentage points.

Are healthcare stocks a good buy now?

61.98% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 27.99% over the next year.

5.22% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.31% of healthcare stocks are rated B (Buy), 48.38% are rated C (Hold), 26% are rated D (Sell), and 7.09% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 29.6x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.